Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Plus Therapeutics Inc (NASDAQ: PSTV) was $0.29 for the day, up 0.17% from the previous closing price of $0.29. In other words, the price has increased by $0.17 from its previous closing price. On the day, 13.12 million shares were traded.
Ratios:
Our analysis of PSTV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 0.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On January 25, 2021, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $8.
On October 16, 2020, Maxim Group started tracking the stock assigning a Buy rating and target price of $6.Maxim Group initiated its Buy rating on October 16, 2020, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 15 ’25 when Petersen Greg bought 36,666 shares for $0.55 per share.
Hawkins Richard J bought 4,000 shares of PSTV for $5,996 on Sep 13 ’24. The Director now owns 15,188 shares after completing the transaction at $1.50 per share. On Sep 12 ’24, another insider, Hawkins Richard J, who serves as the Director of the company, bought 6,285 shares for $1.35 each. As a result, the insider paid 8,512 and bolstered with 11,188 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94.
Stock Price History:
Over the past 52 weeks, PSTV has reached a high of $2.67, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -60.70%, while the 200-Day Moving Average is calculated to be -74.57%.
Shares Statistics:
A total of 17.00M shares are outstanding, with a floating share count of 15.49M. Insiders hold about 8.87% of the company’s shares, while institutions hold 9.41% stake in the company.
Earnings Estimates
The dynamic stock of Plus Therapeutics Inc (PSTV) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.08 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$0.34 and -$1.54 for the fiscal current year, implying an average EPS of -$0.96. EPS for the following year is -$0.88, with 3.0 analysts recommending between -$0.53 and -$1.14.
